{"result": "(\"entity\"<|>ESPEN<|>ORGANIZATION<|>ESPEN is an organization that provides guidelines and recommendations for nutritional support in patients with renal insufficiency.)\n##\n(\"entity\"<|>SODIO<|>GEO<|>Sodio is a mineral that should be limited to 1000 mg/day in patients with renal insufficiency.)\n##\n(\"entity\"<|>POTASIO<|>GEO<|>Potasio is a mineral that should be limited to 40-60 mEq/day in patients with renal insufficiency.)\n##\n(\"entity\"<|>CALCIO<|>GEO<|>Calcio is a mineral that should be supplemented to 1500-2000 mg/day for patients with renal insufficiency.)\n##\n(\"entity\"<|>VITAMINA D<|>GEO<|>VITAMINA D is a vitamin that should be supplemented to maintain adequate levels in patients with renal insufficiency.)\n##\n(\"entity\"<|>VITAMINA B6<|>GEO<|>VITAMINA B6 is a vitamin that should be supplemented at 5 mg/day for patients with renal insufficiency.)\n##\n(\"entity\"<|>VITAMINA C<|>GEO<|>VITAMINA C is a vitamin that should be supplemented at 30-50 mg/day for patients with renal insufficiency.)\n##\n(\"entity\"<|>ERITROPOYETINA<|>GEO<|>Eritropoyetina is a treatment that may require iron supplementation in patients with renal insufficiency.)\n##\n(\"entity\"<|>NUTRICIÓN ENTERAL<|>EVENT<|>NUTRICIÓN ENTERAL refers to the method of providing nutrition through the gastrointestinal tract when oral intake is insufficient.)\n##\n(\"relationship\"<|>ESPEN<|>SODIO<|>ESPEN recommends limiting sodium intake to 1000 mg/day for patients with renal insufficiency<|>7)\n##\n(\"relationship\"<|>ESPEN<|>POTASIO<|>ESPEN recommends limiting potassium intake to 40-60 mEq/day for patients with renal insufficiency<|>7)\n##\n(\"relationship\"<|>ESPEN<|>CALCIO<|>ESPEN recommends supplementing calcium to 1500-2000 mg/day for patients with renal insufficiency<|>7)\n##\n(\"relationship\"<|>ESPEN<|>VITAMINA D<|>ESPEN recommends supplementing vitamin D to maintain adequate levels for patients with renal insufficiency<|>7)\n##\n(\"relationship\"<|>ESPEN<|>VITAMINA B6<|>ESPEN recommends supplementing vitamin B6 at 5 mg/day for patients with renal insufficiency<|>7)\n##\n(\"relationship\"<|>ESPEN<|>VITAMINA C<|>ESPEN recommends supplementing vitamin C at 30-50 mg/day for patients with renal insufficiency<|>7)\n##\n(\"relationship\"<|>ESPEN<|>ERITROPOYETINA<|>ESPEN notes that iron supplementation may be necessary for patients receiving erythropoietin<|>6)\n##\n(\"relationship\"<|>NUTRICIÓN ENTERAL<|>ESPEN<|>ESPEN recommends enteral nutrition when oral intake is insufficient for patients with renal insufficiency<|>8)\n<|COMPLETE|>", "input": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: 20 y 50% (creatinina plasmática de 2 a 5 mg/dl o filtrado glomerular 25-70 ml/min) la ingesta de proteínas se reducirá a 0,6 g/kg/día, cifra que se considera la mínima para un adulto sano (la ESPEN recomienda 0,55-0,60). El 60% de la proteína debe ser de alto valor biológico.\n\nc. Con función renal inferior al 20% (creatinina plasmática superior a 8 mg/dl o filtrado glomerular < 25 ml/min) la restricción proteica alcanzará los 0,30 g/kg/día (0,55-0,6 con 2/3 de proteína de alto valor biológico según la ESPEN).\n\nd. Con función renal inferior (filtrado glomerular < 10 ml/min) ya se puede ser tributario de depuración extrarrenal; solo si esta no fuera posible se\n---\nTema 15. Soporte nutricional en la insuficiencia renal aguda y crónica. Síndrome nefrótico 263\n\nllegaría a una dieta con un aporte < 0,28 g/kg/día, que se suplementaría con aminoácidos esenciales o sus cetoanálogos.\n\nEl mecanismo de acción de las dietas hipoproteicas no se conoce bien. Parece que disminuyen la producción de glucagón y prostaglandinas, evitando así la vasodilatación y por tanto la hiperfiltración glomerular y el deterioro de función, al tiempo que harían disminuir la demanda de oxígeno y, por ende, la producción de radicales libres. Además, también disminuyen la producción de diversos mediadores de la inflamación que dañan el riñón, como renina, citoquinas y lípidos bioactivos.\n\n## Hidratos de carbono\n\nDeben suponer la principal fuente de energía, en torno al 60% a expensas de hidratos de carbono complejos; dada la restricción de proteínas, se recomiendan las pastas y patatas, y menos las legumbres y verduras por contener potasio y proteínas de poco valor biológico.\n\n## Lípidos\n\nFrecuentemente, estos pacientes tienen hiperlipoproteinemia con aumento de las lipoproteínas de baja densidad (LDL y VLDL) y de triglicéridos. La distribución del aporte de grasas, que supone el 30% de las kilocalorías, se ajustará a este hecho. Orientativamente, se reparte en menos del 10% de grasas saturadas y por encima del 10% de monoinsaturadas. La cantidad de colesterol diaria recomendada es de menos de 300 mg/día.\n\n## Electrolitos\n\nAproximadamente, se debe limitar la ingesta de sodio a 1000 mg/día y de potasio a 40-60 mEq/día. Para ello, se deben enseñar a los pacientes técnicas de cocción adecuadas (hervir varias veces la verdura desechando el agua), restringir las frutas y vigilar el uso de fármacos.\n\n## Minerales y oligoelementos\n\nLos pacientes presentan un déficit en la absorción de calcio intestinal por déficit de vitamina D3, por lo que deben suplementarse el calcio de 1500-2000 mg/día y la vitamina D para mantener niveles plasmáticos de 25-OH-Vitamina D > 30 g/dl. Por el contrario, para restringir el consumo de fósforo a 5-10 mg/kg/día, limitar el consumo de lácteos, huevos, carne y algunas verduras, puesto que el aumento de fósforo contribuye al hiperparatiroidismo y al deterioro de la función renal. Suele ser preciso utilizar quelantes por vía oral. El hierro debe ser aportado en aquellos que reciben tratamiento con eritropoyetina.\n\n## Vitaminas\n\nDebe suplementarse las siguientes vitaminas:\n\n- Vitamina B6: 5 mg/día\n- Vitamina D (1,25 dihidroxivitamina D): 0,25 μg/día.\n- Vitamina C: 30-50 mg/día.\n\nCon objeto de asegurar una ingesta adecuada, diversos estudios29, 30 analizan los efectos de la combinación de una dieta baja en proteínas con suplementos nutricionales que permitan asegurar un aporte proteico ajustado a los requerimientos. La revisión de todos ellos permite concluir que dicha combinación mejora el estado nutricional del paciente, frena la evolución de la nefropatía y mejora el perfil lipídico, además de ser bien tolerado por el paciente, alcanzando un grado de recomendación B.\n\nLa vía de administración preferible es la oral siempre que se tolere, pudiendo recurrir a nutrición enteral completa o parcial cuando la ingesta sea insuficiente. Hay que tener en cuenta que la situación metabólica de los pacientes favorece los trastornos gastrointestinales,\n######################\nOutput:", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": null}